Search Results - "Bockisch, A"

Hepatic volume changes after lobar selective internal radiation therapy (SIRT) of hepatocellular carcinoma by Theysohn, J.M, Ertle, J, Müller, S, Schlaak, J.F, Nensa, F, Sipilae, S, Bockisch, A, Lauenstein, T.C

“…Aim To assess volume changes of treated and non-treated liver segments after selective internal radiation therapy (SIRT) in patients with hepatocellular…”
Get full text

Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients by Riegger, C., Herrmann, J., Nagarajah, J., Hecktor, J., Kuemmel, S., Otterbach, F., Hahn, S., Bockisch, A., Lauenstein, T., Antoch, G., Heusner, T. A.

“…Purpose This retrospective study aimed (1) to compare the diagnostic accuracy of whole-body FDG PET/CT for initial breast cancer staging with the accuracy of a…”
Get full text

Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease by Frilling, A., Li, J., Malamutmann, E., Schmid, K.-W., Bockisch, A., Broelsch, C. E.

“…Background: Hepatic surgery is presumed to improve survival of patients with liver metastases (LM) from neuroendocrine tumours (NET). This study identified…”
Get full text

The effect of MR surface coils on PET quantification in whole-body PET/MR: Results from a pseudo-PET/MR phantom study by Tellmann, L., Quick, H. H., Bockisch, A., Herzog, H., Beyer, T.

“…Purpose: The use of magnetic resonance (MR) radiofrequency (RF) surface coils is a prerequisite for high-quality positron emission tomography (PET)/MR imaging…”
Get full text

Imaging with (124)I in differentiated thyroid carcinoma: is PET/MRI superior to PET/CT? by Binse, I, Poeppel, T D, Ruhlmann, M, Gomez, B, Umutlu, L, Bockisch, A, Rosenbaum-Krumme, S J

“…The aim of this study was to compare integrated PET/CT and PET/MRI for their usefulness in detecting and categorizing cervical iodine-positive lesions in…”
Get full text

Detection of inflammation in patients with acute aortic syndrome: comparison of FDG-PET/CT imaging and serological markers of inflammation by Kuehl, H, Eggebrecht, H, Boes, T, Antoch, G, Rosenbaum, S, Ladd, S, Bockisch, A, Barkhausen, J, Erbel, R

“…A substantial number of patients with acute aortic syndrome (AAS) require invasive therapy because of disease progression. Our study aimed to assess the impact…”
Get more information

PET/CT for the staging and follow-up of patients with malignancies by Poeppel, T.D, Krause, B.J, Heusner, T.A, Boy, C, Bockisch, A, Antoch, G

“…Abstract Positron emission tomography (PET) and computed tomography (CT) complement each other's strengths in integrated PET/CT. PET is a highly sensitive…”
Get full text

Quantitative imaging of (124)I with PET/ CT in pretherapy lesion dosimetry. Effects impairing image quantification and their corrections by Jentzen, W, Freudenberg, L, Bockisch, A

“…Iodine-131-labelled agents are successfully used in cancer treatment. In the pretherapy dosimetry approach, positron emission tomography/computed tomography…”
Get full text

Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy by Görges, R, Maniecki, M, Jentzen, W, Sheu, Sie n-Yi, Mann, K, Bockisch, A, Janssen, O E

“…Objective and design: Cross-sectional studies have reported an increased prevalence of circulating thyroglobulin autoantibodies (TgAbs) in patients with…”
Get full text

FDG-PET/CT in re-staging of patients with lymphoma by Freudenberg, L S, Antoch, G, Schütt, P, Beyer, T, Jentzen, W, Müller, S P, Görges, R, Nowrousian, M R, Bockisch, A, Debatin, J F

“…The aim of this study was to evaluate the clinical significance of combined fluorine-18 fluorodeoxyglucose positron emission tomography and computed tomography…”
Get full text

Selective internal radiation therapy of hepatic tumours: Is coiling of the gastroduodenal artery always beneficial? by Schelhorn, J, Theysohn, J, Ertle, J, Schlaak, J.F, Mueller, S, Bockisch, A, Lauenstein, T

“…Aim To assess the effect of gastroduodenal artery (GDA) occlusion prior to selective internal radiation therapy (SIRT) with regards to arterial…”
Get full text

Neural substrates of good and poor recovery after hemiplegic stroke: a serial pet study by Nelles, G., Jentzen, W., Bockisch, A., Diener, H. C.

“…In this study, we used positron emission tomography (PET) at two different time points to study the temporal evolution of reorganization in patients with good…”
Get full text

PO-0670: Decrease in tumor SUVmax during definitive or neoadjuvant RT/CT is a prognostic factor in LAD lung cancer by Stuschke, M, Pöttgen, C, Abu Jawad, J, Gauler, T, Guberina, M, Bockisch, A, Stamatis, G, Eberhardt, W

Get full text

Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results by Heusch, P, Buchbender, C, Köhler, J, Nensa, F, Beiderwellen, K, Kühl, H, Lanzman, R S, Wittsack, H J, Gomez, B, Gauler, T, Schuler, M, Forsting, M, Bockisch, A, Antoch, G, Heusner, T A

“…To compare the apparent diffusion coefficient (ADC) in non-small cell lung cancer lesions with standardized uptake values (SUV) derived from combined…”
Get more information

Chemotherapy with doxorubicin in progressive medullary and thyroid carcinoma of the follicular epithelium by Matuszczyk, A, Petersenn, S, Bockisch, A, Gorges, R, Sheu, S Y, Veit, P, Mann, K

“…Twenty-two patients (mean age 61) with metastasizing, progressive, nonradioiodine-accumulating thyroid carcinoma of the follicular epithelium were treated with…”
Get more information

P1003 SELECTIVE INTERNAL RADIOTHERAPY WITH YTTRIUM-90 MICROSPHERES FOR HEPATOCELLULAR CARCINOMA WITH PORTAL VEIN THROMBOSIS by El Fouly, A, Dechêne, A, Best, J, Mueller, S, Lauenstein, T, Bockisch, A, Gerken, G

Get full text

Pioglitazone therapy in progressive differentiated thyroid carcinoma by Rosenbaum-Krumme, S J, Bockisch, A, Nagarajah, J

“…Rosiglitazone achieved promising results in progressive differentiated thyroid carcinoma (DTC) with redifferentiative and antiproliferative effects, but has…”
Get more information

Expression of the cAMP binding protein EPAC1 in thyroid tumors and growth regulation of thyroid cells and thyroid carcinoma cells by EPAC proteins by Broecker-Preuss, M, Baten, J, Sheu-Grabellus, S-Y, Görges, R, Bockisch, A, Schmid, K W, Führer, D, Mann, K

“…The thyrotropin receptor-cAMP pathway is central in growth regulation of thyroid cells and thyroid tumorigenesis, and it regulates expression of thyroid…”
Get more information

Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German Guideline (S1) by Poeppel, T D, Boy, C, Bockisch, A, Kotzerke, J, Buchmann, I, Ezziddin, S, Scheidhauer, K, Krause, B J, Schmidt, D, Amthauer, H, Rösch, F, Nagarajah, J, Führer, D, Lahner, H, Pöpperl, G, Hörsch, D, Walter, M A, Baum, R P

“…This document describes the guideline for peptide receptor radionuclide therapy (PRRT) published by the German Society of Nuclear Medicine (DGN) and accepted…”
Get more information

256 LONG TERM CLINICAL AND BIOCHEMICAL COMPARATIVE ANALYSIS AFTER SELECTIVE INTERNAL RADIOTHERAPY WITH YTTRIUM-90 MICROSPHERES IN HEPATOCELLULAR CARCINOMA by El Fouly, A, Ertle, J, Mueller, S, Lauenstein, T, Bockisch, A, Gerken, G, Dechêne, A, Schlaak, J.F

Get full text